Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:18 pm Purchase |
2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
A.G.P. / Alliance Global Partners, LLC | 73,888 9.800% |
73,888 (New Position) |
Filing History |
| 2025-05-07 5:36 pm Purchase |
2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
Sarborg Ltd | 123,596 16.400% |
123,596 (New Position) |
Filing History |
| 2025-04-10 06:00 am Sale |
2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 4,926 1.100% |
-1,410 (-22.26%) |
Filing History |
| 2025-02-20 4:32 pm Sale |
2025-02-19 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 0 0.000% |
-10,233 (Position Closed) |
Filing History |
| 2025-01-21 5:00 pm Purchase |
2025-01-13 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 10,233 9.979% |
8,900 (+667.50%) |
Filing History |
| 2024-11-06 06:01 am Sale |
2024-09-03 | 13G | Conduit Pharmaceuticals Inc. CDT |
St George Street Capital | 0 0.000% |
-3,167 (Position Closed) |
Filing History |
| 2024-10-18 4:15 pm Sale |
2024-10-11 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 1,333 2.000% |
-4,061 (-75.28%) |
Filing History |
| 2024-10-11 06:01 am Purchase |
2024-08-07 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 6,336 9.900% |
6,336 (New Position) |
Filing History |
| 2024-10-07 7:36 pm Sale |
2024-10-04 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 5,395 8.300% |
-4,272 (-44.19%) |
Filing History |
| 2024-09-19 4:59 pm Sale |
2024-03-26 | 13D | Conduit Pharmaceuticals Inc. CDT |
Corvus Capital Ltd. | 20,195 31.560% |
-10,201 (-33.56%) |
Filing History |
| 2024-08-13 4:29 pm Purchase |
2024-08-06 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 9,667 14.800% |
5,320 (+122.38%) |
Filing History |
| 2024-02-12 12:51 pm Purchase |
2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
Polar Asset Management Partners Inc. | 633 1.300% |
633 (New Position) |
Filing History |
| 2024-02-08 1:15 pm Unchanged |
2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
Saba Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-02 4:28 pm Purchase |
2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
Hudson Bay Capital Management LP | 49 0.100% |
49 (New Position) |
Filing History |
| 2023-10-02 4:30 pm Purchase |
2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT |
Nirland Limited | 4,347 8.800% |
4,347 (New Position) |
Filing History |
| 2023-09-29 4:30 pm Purchase |
2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT |
Corvus Capital Ltd. | 30,396 62.960% |
30,396 (New Position) |
Filing History |
| 2023-09-29 4:30 pm Purchase |
2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT |
Murphy Canyon Acquisition Sponsor LLC | 3,150 6.500% |
3,150 (New Position) |
Filing History |
| 2023-09-29 4:30 pm Purchase |
2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT |
St George Street Capital | 3,167 6.600% |
3,167 (New Position) |
Filing History |
| 2023-02-16 5:28 pm Purchase |
2022-02-13 | 13D | Murphy Canyon Acquisition Corp. MURF |
Shaolin Capital Management LLC | 609,750 20.730% |
609,750 (New Position) |
Filing History |
| 2023-02-14 12:08 pm Purchase |
2022-12-31 | 13G | Murphy Canyon Acquisition Corp. MURF |
MMCAP International Inc. SPC | 350,000 2.500% |
350,000 (New Position) |
Filing History |